imatinib mesylate has been researched along with Langerhans Cell Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, NY; Lee, FY; Wang, J; Wen, MC | 1 |
1 other study(ies) available for imatinib mesylate and Langerhans Cell Sarcoma
| Article | Year |
|---|---|
Langerhans Cell Sarcoma in a Chronic Myelogenous Leukemia Patient Undergoing Imatinib Mesylate Therapy: A Case Study and Review of the Literature.
Topics: Aged; Female; Humans; Imatinib Mesylate; Langerhans Cell Sarcoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2014 |